3rd Quarter - Report

ACG ADVOCACY for GENENTECH INC

Period 3rd Quarter 2018 Filed Oct 18, 2018 Signed by David J. Urban

Official filing
Firm
ACG ADVOCACY
Client
GENENTECH INC
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Drug pricing issues.

LobbyistCovered position, as disclosed
CHRIS ISRAEL —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Trade Negotiations. Trade Policy Issues.

LobbyistCovered position, as disclosed
CHRIS ISRAEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Copyright/Patent/Trademark CPT

General IP Issues. Patent Litigation Reform.

LobbyistCovered position, as disclosed
CHRIS ISRAEL U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.